0001127602-16-046112.txt : 20160311
0001127602-16-046112.hdr.sgml : 20160311
20160311165255
ACCESSION NUMBER: 0001127602-16-046112
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160309
FILED AS OF DATE: 20160311
DATE AS OF CHANGE: 20160311
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INSULET CORP
CENTRAL INDEX KEY: 0001145197
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043523891
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 600 TECHNOLOGY PARK
STREET 2: SUITE 200
CITY: BILLERICA
STATE: MA
ZIP: 01821
BUSINESS PHONE: 978-600-7000
MAIL ADDRESS:
STREET 1: 600 TECHNOLOGY PARK
STREET 2: SUITE 200
CITY: BILLERICA
STATE: MA
ZIP: 01821
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEVANGIE DANIEL J
CENTRAL INDEX KEY: 0001187406
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33462
FILM NUMBER: 161501347
MAIL ADDRESS:
STREET 1: 85 SWANSON ROAD
CITY: BOXBOROUGH
STATE: MA
ZIP: 01719
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2016-03-09
0001145197
INSULET CORP
PODD
0001187406
LEVANGIE DANIEL J
C/O INSULET CORPORATION
600 TECHNOLOGY PARK DRIVE, SUITE 200
BILLERICA
MA
01821
1
President, Drug Delivery
Common Stock
2016-03-09
4
M
0
15545
15.14
A
25358
D
Common Stock
2016-03-09
4
S
0
7600
31.04
D
17758
D
Common Stock
2016-03-10
4
M
0
9455
15.14
A
27213
D
Common Stock
2016-03-10
4
S
0
4699
30.65
D
22514
D
Stock Option (Right to Buy)
15.14
2016-03-09
4
M
0
15545
0
D
2021-11-01
Common Stock
15545
9455
D
Stock Option (Right to Buy)
15.14
2016-03-10
4
M
0
9455
0
D
2021-11-01
Common Stock
9455
0
D
Includes 1,000 restricted stock units granted on June 3, 2013, which vest on April 30, 2016; 2,000 restricted stock units granted on June 2, 2014, which vest one-half of the total units on April 30, 2016 and one-half of the total units on April 30, 2017; and 6,813 performance share units granted on April 1, 2015, which vest one-third of the total performance share units on April 1, 2016, one-third of the total performance share units on April 1, 2017 and one-third of the performance share units on April 1, 2018, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.
The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $31.00 to $31.46. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $30.12 to $31.00. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
This option is subject to a three-year vesting period with 50% of the total award vesting on the first anniversary of the date of grant and 25% on each of the second and third anniversaries of the date of grant, subject to continued service as a director or consultant.
/s/ David Colleran, attorney-in-fact
2016-03-11